Placental growth factor influences maternal cardiovascular adaptation to pregnancy in mice

Biology of Reproduction

Volumn 92, Issue 2, 2015, Pages

  Aasa, Kristiina L ^a   Zavan, Bruno ^a,b   Luna, Rayana L ^a,c   Wong, Philip G ^a   Ventura, Nicole M ^a   Tse, M Yat ^a   Carmeliet, Peter ^d,e   Adams, Michael A ^a   Pang, Stephen C ^a   Croy, B Anne ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cardiac remodeling; Cardiovascular risk; Fetal growth; Placenta; Ultrasound

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; ATRIAL NATRIURETIC FACTOR BETA; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C; NEURONAL NITRIC OXIDE SYNTHASE; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; NITRIC OXIDE SYNTHASE; PLACENTA PROTEIN;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FETUS; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART STROKE VOLUME; HEART WEIGHT; KIDNEY HYPERTROPHY; KIDNEY MASS; LITTER SIZE; MATERNAL PLASMA; MOUSE; NONHUMAN; PLETHYSMOGRAPHY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; TISSUE STRUCTURE; UPREGULATION; ANIMAL; BLOOD PRESSURE; GENE EXPRESSION; GENETICS; HEART; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLACENTA;

MUS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; FEMALE; GENE EXPRESSION; HEART; KIDNEY; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; PLACENTA; PREGNANCY; PREGNANCY PROTEINS;

EID: 84929590098     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.114.124677     Document Type: Article

References (48)

1. Vrachnis N, Kalampokas E, Sifakis S, Vitoratos N, Kalampokas T, Botsis D, Iliodromiti Z. Placental growth factor (PlGF): a key to optimizing fetal growth. J Matern Fetal Neonatal Med 2013; 26:995-1002.
2. Iwasaki H, Kawamoto A, Tjwa M, Horii M, Hayashi S, Oyamada A, Matsumoto T, Suehiro S, Carmeliet P, Asahara T. PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors. PLoS One 2011; 6:e24872.
3. Carnevale D, Lembo G. Placental growth factor and cardiac inflammation. Trends Cardiovasc Med 2012; 22:209-212.
4. Luttun A, Tjwa M, Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci 2002; 979:80-93.
5. Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2008; 2:249-259.
6. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68:540-543.
7. Tsiaras S, Poppas A. Cardiac disease in pregnancy: value of echocardiography. Curr Cardiol Rep 2010; 12:250-256.
8. Harris LK, Aplin JD. Vascular remodeling and extracellular matrix breakdown in the uterine spiral arteries during pregnancy. Reprod Sci 2007; 14:28-34.
9. Tayade C, Hilchie D, He H, Fang Y, Moons L, Carmeliet P, Foster RA, Croy BA. Genetic deletion of placenta growth factor in mice alters uterine NK cells. J Immunol 2007; 178:4267-4275.
10. Ratsep MT, Carmeliet P, Adams MA, Croy BA. Impact of placental growth factor deficiency on early mouse implant site angiogenesis. Placenta 2014; 35:772-775.
11. Welch PC, Amankwah KS, Miller P, McAsey ME, Torry DS. Correlations of placental perfusion and PlGF protein expression in early human pregnancy. Am J Obstet Gynecol 2006; 194:1625-1629 (discussion 1629-1631).
12. De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med 2012; 44:1-9.
13. Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond) 2012; 122:43-52.
14. Dewerchin M, Carmeliet P. PlGF: a multitasking cytokine with diseaserestricted activity. Cold Spring Harb Perspect Med 2012; 2:a011056.
15. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7:575-583.
16. Ratsep MT, Felker AM, Kay VR, Tolusso L, Hofmann AP, Croy BA. Uterine natural killer cells: supervisors of vasculature construction in early decidua basalis. Reproduction 2015; 149:R91-R102.
17. Burke SD, Barrette VF, Bianco J, Thorne JG, Yamada AT, Pang SC, Adams MA, Croy BA. Spiral arterial remodeling is not essential for normal blood pressure regulation in pregnant mice. Hypertension 2010; 55:729-737.
18. Armstrong DW, Tse MY, Wong PG, Ventura NM, Meens JA, Johri AM, Matangi MF, Pang SC. Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction. Mol Cell Biochem 2014; 391:201-209.
19. Wong PG, Armstrong DW, Tse MY, Brander EP, Pang SC. Sex-specific differences in natriuretic peptide and nitric oxide synthase expression in ANP gene-disrupted mice. Mol Cell Biochem 2013; 374:125-135.
20. Melchiorre K, Sharma R, Thilaganathan B. Cardiac structure and function in normal pregnancy. Curr Opin Obstet Gynecol 2012; 24:413-421.
21. Powers RW, Roberts JM, Plymire DA, Pucci D, Datwyler SA, Laird DM, Sogin DC, Jeyabalan A, Hubel CA, Gandley RE. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension 2012; 60:239-246.
22. Alahakoon TI, Zhang W, Trudinger BJ, Lee VW. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles. J Matern Fetal Neonatal Med 2014; 27:1854-1859.
23. Molvarec A, Gullai N, Stenczer B, Fugedi G, Nagy B, Rigo J Jr. Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study. BMC Pregnancy Childbirth 2013; 13:161.
24. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in humans and experimental animals. Part 2. Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 2005; 45:299-310.
25. Tejera E, Areias MJ, Rodrigues AI, Nieto-Villar JM, Rebelo I. Blood pressure and heart rate variability complexity analysis in pregnant women with hypertension. Hypertens Pregnancy 2012; 31:91-106.
26. Hofmann AP, Gerber SA, Croy BA. Uterine natural killer cells pace early development of mouse decidua basalis. Mol Hum Reprod 2014; 20:66-76.
27. Kasdaglis T, Aberdeen G, Turan O, Kopelman J, Atlas R, Jenkins C, Blitzer M, Harman C, Baschat AA. Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studies. Ultrasound Obstet Gynecol 2010; 35:280-285.
28. Tjwa M, Luttun A, Autiero M, Carmeliet P. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res 2003; 314:5-14.
29. Accornero F, van Berlo JH, Benard MJ, Lorenz JN, Carmeliet P, Molkentin JD. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 2011; 109:272-280.
30. Kulandavelu S, Qu D, Adamson SL. Cardiovascular function in mice during normal pregnancy and in the absence of endothelial NO synthase. Hypertension 2006; 47:1175-1182.
31. Savu O, Jurcut R, Giusca S, van Mieghem T, Gussi I, Popescu BA, Ginghina C, Rademakers F, Deprest J, Voigt JU. Morphological and functional adaptation of the maternal heart during pregnancy. Circ Cardiovasc Imaging 2012; 5:289-297.
32. Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, Onoue K, Okayama S, Somekawa S, Kida Y, Takeda Y, Nakatani K, et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 2006; 47:1559-1567.
33. Gmeiner M, Zimpfer D, Holfeld J, Seebacher G, Abraham D, Grimm M, Aharinejad S. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor. J Thorac Cardiovasc Surg 2011; 141:1238-1245.
34. Jaba IM, Zhuang ZW, Li N, Jiang Y, Martin KA, Sinusas AJ, Papademetris X, Simons M, Sessa WC, Young LH, Tirziu D. NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth. J Clin Invest 2013; 123:1718-1731.
35. Gigante B, Morlino G, Gentile MT, Persico MG, De Falco S. Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia. FASEB J 2006; 20:970-972.
36. Romero M, Caniffi C, Bouchet G, Elesgaray R, Laughlin MM, Tomat A, Arranz C, Costa MA. Sex differences in the beneficial cardiac effects of chronic treatment with atrial natriuretic peptide in spontaneously hypertensive rats. PLoS One 2013; 8:e71992.
37. Wong J, Chang C, Agrawal R, Walton GB, Chen C, Murthy A, Patterson AJ. Gene expression profiling: classification of mice with left ventricle systolic dysfunction using microarray analysis. Crit Care Med 2010; 38:25-31.
38. Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, van Haperen R, de Crom R, Kawashima S, Yokoyama M, Lefer DJ. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2004; 286: H276-H282.
39. Manoury B, Montiel V, Balligand JL. Nitric oxide synthase in postischaemic remodelling: new pathways and mechanisms. Cardiovasc Res 2012; 94:304-315.
40. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, Han H, Laubach VE, Ping P, Yang Z, Qiu Y, Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A 1999; 96:11507-11512.
41. Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal 2009; 11:1913-1928.
42. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
43. Ogueh O, Clough A, Hancock M, Johnson MR. A longitudinal study of the control of renal and uterine hemodynamic changes of pregnancy. Hypertens Pregnancy 2011; 30:243-259.
44. Osol G, Celia G, Gokina N, Barron C, Chien E, Mandala M, Luksha L, Kublickiene K. Placental growth factor is a potent vasodilator of rat and human resistance arteries. Am J Physiol Heart Circ Physiol 2008; 294: H1381-H1387.
45. Tarry-Adkins JL, Martin-Gronert MS, Fernandez-Twinn DS, Hargreaves I, Alfaradhi MZ, Land JM, Aiken CE, Ozanne SE. Poor maternal nutrition followed by accelerated postnatal growth leads to alterations in DNA damage and repair, oxidative and nitrosative stress, and oxidative defense capacity in rat heart. FASEB J 2013; 27:379-390.
46. Singhal A, Cole TJ, Fewtrell M, Deanfield J, Lucas A. Is slower early growth beneficial for long-term cardiovascular health? Circulation 2004; 109:1108-1113.
47. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999; 318:427-431.
48. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122:1122-1131.